Latest news
- General
- IP news
- Newsletter
- Trademarks
- Patents
Our October newsletter is here!
Read more | Our October newsletter is here!
De Clercq & Partners Celebrate MIP Recognitions
Read more | De Clercq & Partners Celebrate MIP Recognitions
UPC’s first revocation decision takes the EPO approach on antibody inventions a step further
Read more | UPC’s first revocation decision takes the EPO approach on antibody inventions a step further
Scientific reality is taken into account by The Hague Local Division of the UPC in granting preliminary injunction
Read more | Scientific reality is taken into account by The Hague Local Division of the UPC in granting preliminary injunction
- IP news
- Patents
Brainwave to breakthrough: EEG data as Intellectual Property
Read more | Brainwave to breakthrough: EEG data as Intellectual Property
Free Webinar: Navigating challenges to patenting Software and AI Inventions in the US & Europe
Read more | Free Webinar: Navigating challenges to patenting Software and AI Inventions in the US & Europe
- General
Meet De Clercq & Partners at BIO-Europe 2024 in Stockholm!
Read more | Meet De Clercq & Partners at BIO-Europe 2024 in Stockholm!
- IP news
- UP & UPC
- Patents
Timeline of Infringement and Revocation Actions Before the Unified Patent Court (UPC)
Read more | Timeline of Infringement and Revocation Actions Before the Unified Patent Court (UPC)
- IP news
- Patents
Use of an infant formula for promoting growth is not a method of treatment by therapy
Read more | Use of an infant formula for promoting growth is not a method of treatment by therapy
- Patents
- IP news
T2360/19 reasoning confirms the impact of G1/22 and G2/22 on formal priority in the Broad, MIT and Harvard CRISPR cases
Read more | T2360/19 reasoning confirms the impact of G1/22 and G2/22 on formal priority in the Broad, MIT and Harvard CRISPR cases
- General
Koen Vanhalst Named One of the World's Leading IP Strategists for 2024 by IAM Strategy 300
Read more | Koen Vanhalst Named One of the World's Leading IP Strategists for 2024 by IAM Strategy 300
- Patents
- IP news
G 1/24 : Enlarged Board of Appeal referral on claim interpretation
Read more | G 1/24 : Enlarged Board of Appeal referral on claim interpretation
- Trademarks
- IP news
Ambush Marketing: How organizers rein in free riding on sports’ appeal
Read more | Ambush Marketing: How organizers rein in free riding on sports’ appeal